Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Undifferentiated carcinoma of liver and intrahepatic biliary tract is an extremely rare epithelial tumor of the liver and biliary tract which presents heterogenous histological findings and not yet fully defined clinicopathological characteristics. Patients usually present with nonspecific signs and symptoms, such as abdominal pain, nausea, vomiting, anorexia, weight loss and/or jaundice. Invasive growth, high metastatic potential and a rapid clinical course are typically associated.
Biomarker and diagnostic research for undifferentiated carcinoma of liver and intrahepatic biliary tract has been reported in the published literature.
No clinical trials have been registered for undifferentiated carcinoma of liver and intrahepatic biliary tract.
186 publications have been identified in PubMed for undifferentiated carcinoma of liver and intrahepatic biliary tract. Research spans Review / Meta-Analysis (31%), Epidemiology / Natural History (18%), and Basic Science / Preclinical (15%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 50 | 31% |
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 10:21 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Disease patterns and progression |
29 |
18% |
Laboratory research | 25 | 15% |
Patient case studies | 20 | 12% |
Clinical study results | 20 | 12% |
Testing and diagnosis research | 16 | 10% |
New treatment approaches | 2 | 1% |
Jang A (2026). [PMID: 41781899](https://pubmed.ncbi.nlm.nih.gov/41781899/). *BMC Gastroenterol*. [Epidemiology / Natural History]
Milardi G (2026). [PMID: 40889886](https://pubmed.ncbi.nlm.nih.gov/40889886/). *Gut*. [Basic Science / Preclinical]
Shi GM (2026). [PMID: 41780001](https://pubmed.ncbi.nlm.nih.gov/41780001/). *N Engl J Med*. [Clinical Trial Publication]
El Homsi M (2026). [PMID: 40944876](https://pubmed.ncbi.nlm.nih.gov/40944876/). *Abdom Radiol (NY)*. [Review / Meta-Analysis]
Martin A (2026). [PMID: 41724623](https://pubmed.ncbi.nlm.nih.gov/41724623/). *Dig Liver Dis*. [Diagnostic / Biomarker]
Liao Q (2026). [PMID: 41770674](https://pubmed.ncbi.nlm.nih.gov/41770674/). *J Vis Exp*. [Clinical Trial Publication]
Pang C (2026). [PMID: 41528222](https://pubmed.ncbi.nlm.nih.gov/41528222/). *Radiology*. [Epidemiology / Natural History]
Chen TI (2026). [PMID: 40117647](https://pubmed.ncbi.nlm.nih.gov/40117647/). *Hepatology*. [Epidemiology / Natural History]
VanSant-Webb CH (2026). [PMID: 41207158](https://pubmed.ncbi.nlm.nih.gov/41207158/). *Am J Surg*. [Basic Science / Preclinical]
Wang YH (2026). [PMID: 41771518](https://pubmed.ncbi.nlm.nih.gov/41771518/). *Zhonghua Wai Ke Za Zhi*. [Review / Meta-Analysis]